Descriptive Epidemiology of Thyroid Cancers in Togo

  • Darre, Tchin (Department of Pathology, University Teaching Hospital) ;
  • Amana, Bathokedeou (Department of Head and Neck Surgical, University Teaching Hospital) ;
  • Pegbessou, Essobozou (Department of Head and Neck Surgical, University Teaching Hospital) ;
  • Bissa, Harefeteguena (Department of Stomatology, University Teaching Hospital) ;
  • Amegbor, Koffi (Department of Pathology, University Teaching Hospital) ;
  • Boko, Essohanam (Department of Head and Neck Surgical, University Teaching Hospital) ;
  • Kpemessi, Eyawelohn (Department of Head and Neck Surgical, University Teaching Hospital) ;
  • Napo-Koura, Gado (Department of Pathology, University Teaching Hospital)
  • Published : 2015.10.06


Background: The purpose of this study was to provide epidemiological and histological data of thyroid cancers in Togo. Materials and Methods: This was a retrospective cross-sectional study of cases of thyroid cancers diagnosed from 2000 to 2014 (15 years) at the pathology laboratory of the Sylvanus Olympio Teaching Hospital of $Lom{\acute{e}}$. All cases of review of a thyroid sample (biopsies, surgical specimens) were collected from the data records of that laboratory. Results: Thyroid cancers represented 1.1% (7930cases) of all cancers registered during the study period. Mean age was $45.4{\pm}0.3$ years and the proportion of females was 78.3%. We identified 92.4% carcinomas and 7.6% lymphomas. Carcinomas were well differentiated in 80 cases and were dominated by the papillary type (47 cases). Metastasis was observed in 13% of patients. The pTNM classification evaluated in 18 cases showed a predominance of grade I (13 cases). Lymphomas were dominated by lymphoma diffuse large B-cell (5 cases). Conclusions: This study is the first global standard for thyroid cancer pathology in Togo. The high frequency of follicular form suggests an unrecognized iodine deficiency. The improvement of the technical platform of the LAP (immunohistochemistry) will increase the diagnosis of rare forms of thyroid cancer.




  1. Belot A, Grosclaude P, Bossard N, et al (2008). Cancer incidence and mortality in France over the period 1980-2005. Epidemiol Rev Public Health, 56, 159-75.
  2. Carling T Udelsman R (2014). Thyroid cancer. Annu Rev Med, 65, 125-37.
  3. Colonna M, Bossard N, Guizard AV, et al (2010). Descriptive epidemiology of thyroid cancer. Ann Endocrinol, 71, 95-101.
  4. Colonna M, Guizard AV, Schvartz C, et al (2007). A time trend analysis of papillary and follicular cancers as a function of tumor size: a study of data from cancer registries in six France (1983-2000). Eur J Cancer, 43, 891-900.
  5. Cotterill SJ, Pearce MS, Parker L (2001). Thyroid cancer in children and young adults in the North of England. Increasing incidence is related to the Chernobyl accident? Eur J Cancer, 37, 1020-6.
  6. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S (2009). Risk factoring for thyroid cancer: an epidemiological review Focused on nutritional factoring. Cancer Causes Control 20, 75-86.
  7. Davies L, Welch HG (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164-7.
  8. Hahn K, Schnell-Inderst P, Grosche B, Holm LE (2001). Thyroid cancer diagnosis After administration of iodine-131 in childhood. Radiat Res, 156, 61-70.[0061:TCADAO]2.0.CO;2
  9. Kalk WJ, Sitas F, Patterson AC (1997). Thyroid cancer in South Africa. An indicator of iodine deficiency regional. S Afr Med J, 87, 735-8
  10. Kilfoy BA, Zheng T, Holford TR, et al (2009). International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control, 20, 525-31.
  11. Michels JJ, Delcambre C, Marnay J, et al (2002). Primary thyroid lymphomas: clinicopathologic study of 30 cases and review of the literature. Ann Pathol, 22, 10-7.
  12. Montury S, De Clermont H, Gatina JF (1998). Prevalence of thyroid cancer in Reunion from the scintigraphic data. Bull Soc Pathol Exot, 91, 22-5.
  13. Rakotoarisoa AHN, Ralamboson SA, Rakotoarivelo RA, et al (2010). The thyroid cancers in Madagascar. Bull. Soc Pathol. Exot, 103, 233-7.
  14. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV (2009). Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid, 19, 333-40.
  15. Sassolas G, Hafdi Nejjari-Z, Remontet L, et al (2009). Thyroid cancer incidence is the rise abating? Eur J Endocrinol, 160, 71-9.
  16. Sawka AM, Brierley JD, Ezzat S, Goldstein DP (2014). Managing newly Diagnosed thyroid cancer. CMAJ, 186, 269-75.
  17. Stein SA, Wartofsky L (2013). Primary thyroid lymphoma L. Wartofsky: a clinical review. J Clin Endocrinol Metab, 98, 3131-8.
  18. Zhu C, Zheng T, Kilfoy BA, et al (2009). A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid, 19, 1061-6.